Number of Shares
5.92 Mil
Current Holdings Value*
kr395.87 Mil
% of Portfolio
0.78%
Total Estimate Gain
kr429.81 Mil
% of Total Estimate Gain
19.68%

Fidelity Series Global ex U.S. Index Fund's Novo Nordisk AS Holding Summary

As of 2025-04-30, FIDELITY SALEM STREET TRUST held 5.92 Mil shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr395.87 Mil. This investment constitutes 0.78% of their stock portfolio, and FIDELITY SALEM STREET TRUST now holds 0.13% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then Fidelity Series Global ex U.S. Index Fund has made 20 purchases of OCSE:NOVO B, at an average price of kr349.77, for a total of 6.25 Mil shares. In addition, there have been 2 sales at an average price of kr491.50 for 324,495.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, Fidelity Series Global ex U.S. Index Fund's estimated gain on his OCSE:NOVO B holdings is kr429.81 Mil, reflecting a 19.68% gain to date.

Fidelity Series Global ex U.S. Index Fund OCSE:NOVO B (kr414.60) Holding Chart

Fidelity Series Global ex U.S. Index Fund OCSE:NOVO B (kr414.60) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1